Company
Headquarters: Philadelphia, PA, United States
CEO: Mr. Osagie O. Imasogie Esq.
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $991.39 B |
| JPMorgan | $744.02 B |
| Visa | $635.57 B |
| Mastercard | $490.32 B |
| Bank of America | $353.07 B |
Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Ibere Pharmaceuticals has the following listings and related stock indices.
Stock: NYSE: IBER wb_incandescent